You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
McKinsey
Express Scripts
Merck
Harvard Business School

Last Updated: April 10, 2020

DrugPatentWatch Database Preview

Cyproheptadine hydrochloride - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for cyproheptadine hydrochloride and what is the scope of freedom to operate?

Cyproheptadine hydrochloride is the generic ingredient in two branded drugs marketed by Actavis Mid Atlantic, Anda Repository, Elysium, Halsey, Lannett Co Inc, Lyne, Morton Grove, Naska, Pharm Assoc, Quagen, Merck, Am Therap, Apex Pharms Inc, Ascot, Beximco Pharms Usa, Boscogen, Chartwell Rx, Duramed Pharms Barr, Fosun Pharma, Heritage Pharma, Kv Pharm, Md Pharm, Mountain, Mylan, Novast Labs, Par Pharm, Pioneer Pharms, Pliva, Strides Pharma, Superpharm, Twi Pharms, Vitarine, Watson Labs, and Zydus Pharms, and is included in thirty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for cyproheptadine hydrochloride. Twenty-six suppliers are listed for this compound.

Recent Clinical Trials for cyproheptadine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
ECSORPhase 2
Kinnov TherapeuticsPhase 2
All India Institute of Medical Sciences, BhubaneswarPhase 4

See all cyproheptadine hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for cyproheptadine hydrochloride
Synonyms for cyproheptadine hydrochloride
0S9323MCT0
1-methyl-4-(2-tricyclo[9.4.0.0^{3,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride
1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine hydrochloride
1-Methyl-4-(5-dibenzo[a,e]cycloheptatrienylidene)piperidine hydrochloride
4-(5-Dibenzo(a,e)cycloheptatrienylidene)piperidine hydrochloride
4-(5-Dibenzo[a,e]cycloheptatrienylidene)piperidine hydrochloride
4-(5h-dibenzo [a,d]cyclohepten-5-ylidene)-1-methylpiperidine hydrochloride
4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine hydrochloride
4-(5H-Dibenzo[a,d]cyclohepten-5-yli dine)-methylpiperidine hydrochloride
4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine hydrochloride
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidine)-methylpiperidine hydrochloride
4-(dibenzo[2,1-b:1',2'-e][7]annulen-11-ylidene)-1-methylpiperidine;hydrochloride
41354-29-4
6032-06-0
969-33-5
AB0015125
AB2000448
AC-15790
AI3-26940
AK544118
AKOS015905305
Anarexol
anhydrous cyproheptadine hydrochloride
Antegan
AS-14697
BG0159
C 6022
C21H21N.HCl
CCG-101144
CHEBI:59695
CHEMBL1716
Cipractin
component of Dronactin
Contrallerg
CPD000058431
CS-2423
CTK8F8876
Cycloheptadine HCl
Cycloheptadine hydrochloride
Cypoheptadine hydrochloride
Cyproheptadiene hydrochloride
Cyproheptadine (hydrochloride)
Cyproheptadine chlorhydrate
Cyproheptadine Hcl
cyproheptadine hydrochloride (anh.)
Cyproheptadine Hydrochloride (anhydrous)
Cyproheptadine hydrochloride (Periactin)
Cyproheptadine hydrochloride anhydrous
cyproheptadine hydrochloride hydrate
Cyproheptadine hydrochloride sesquihydrate
Cyproheptadine-hydrochloride
cyproheptadine-hydrochloride-periactin
Cyproheptadine(hydrochloride)
Cyproptadine Hydrochloride,(S)
DTXSID5042586
EINECS 213-535-1
EU-0100246
FT-0603147
HMS1568E08
HMS3414J05
HMS3678J03
HY-B0366A
Istam
J10393
KS-00001F75
Kulinet
Kyliver
LP00246
LS-114934
M230
MLS000028462
MLS001077277
MLS001424281
MLS002222173
NC00394
NCGC00093708-01
NCGC00093708-02
NCGC00260931-01
NSC 169911
NSC-169911
NSC-759282
NSC169911
NSC759282
Nuran
Opera_ID_383
Periactin hydrochloride
Periactin syrup
Periactinol (VAN)
Periactinol hydrochloride
Peritol
Pharmakon1600-01505973
Piperidine, 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-, hydrochloride
Piperidine,d]cyclohepten-5-ylidene)-1-methyl-, hydrochloride
Prestwick_139
Q27126856
REGID_for_CID_13770
s2044
SAM001246883
SC-94573
SCHEMBL41842
Sialotin
SMR000058431
SR-01000003077
SR-01000003077-2
SR-01000003077-4
SR-01000003077-9
SW196450-4
Tox21_500246
UNII-0S9323MCT0
Vinorex
VUFB3511
W-106308
WLN: L C676 BYJ BU- DT6N DYTJ A1 &GH
ZPMVNZLARAEGHB-UHFFFAOYSA-N

US Patents and Regulatory Information for cyproheptadine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quagen CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 212423-001 May 22, 2019 AA RX No No   Start Trial   Start Trial   Start Trial
Pliva CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 088205-001 Jul 26, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Vitarine CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087284-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Fosun Pharma CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 086808-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Superpharm CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087405-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
McKinsey
Express Scripts
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.